(Q35994010)

11 August 2017

Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma (English)

1 reference

https://api.crossref.org/works/10.1038/BJC.1992.61

11 August 2017

1 reference

1 reference

1 reference

13 November 2022

2

E. G. de Vries

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739635

13 November 2022

author name string

de Vries EG

2

1 reference

11 August 2017

N. H. Mulder

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739635

13 November 2022

D. T. Sleijfer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739635

13 November 2022

H. Schraffordt Koops

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739635

13 November 2022

P. H. Willemse

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739635

13 November 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

full work available at URL

11 August 2017

https://europepmc.org/articles/PMC1977744

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739635

https://europepmc.org/articles/PMC1977744?pdf=render

13 November 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739635

http://www.nature.com/articles/bjc199261.pdf

13 November 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/BJC.1992.61

http://www.nature.com/articles/bjc199261

13 November 2022

1 reference

https://api.crossref.org/works/10.1038/BJC.1992.61

British Journal of Cancer

13 November 2022

published in

1 reference

11 August 2017

65

1 reference

11 August 2017

2

1 reference

11 August 2017

303-304

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1992.61

11 August 2017

0 references

cites work

Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977744

Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma

2 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977744

Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites

2 October 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1739635

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1739635

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1992.61

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

1 reference